made in plant cells. GSK is contributing its vaccine adjuvant technology to the programme, which is designed to boost the immune response to the vaccine and potentially also allow it to be given ...
CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 ...
Investor's Business Daily on MSN4mon
GSK Plummets To 10-Month Low As RSV, Shingles Vaccines Hit The SkidsGSK stock plunged to a 10-month low Wednesday after sales of its respiratory syncytial virus vaccine, Arexvy, skidded and ...
TORONTO - Health Canada says it has approved a plan by Mississauga-based GlaxoSmithKline to fix contamination problems it has been experiencing at its Ste. Foy, Que., flu vaccine production plant. The ...
GSK has also advanced vaccine collaborations, including adjuvanted protein-based candidate vaccines with Sanofi and SK bioscience, the adjuvanted plant-based vaccine with Medicago, and next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback